Skip to main content
Top
Published in: BMC Primary Care 1/2005

Open Access 01-12-2005 | Study protocol

Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]

Authors: Matthias Briel, Mirjam Christ-Crain, Jim Young, Philipp Schuetz, Peter Huber, Pierre Périat, Heiner C Bucher, Beat Müller

Published in: BMC Primary Care | Issue 1/2005

Login to get access

Abstract

Background

Acute respiratory tract infections (ARTI) are among the most frequent reasons for consultations in primary care. Although predominantly viral in origin, ARTI often lead to the prescription of antibiotics for ambulatory patients, mainly because it is difficult to distinguish between viral and bacterial infections. Unnecessary antibiotic use, however, is associated with increased drug expenditure, side effects and antibiotic resistance. A novel approach is to guide antibiotic therapy by procalcitonin (ProCT), since serum levels of ProCT are elevated in bacterial infections but remain lower in viral infections and inflammatory diseases.
The aim of this trial is to compare a ProCT-guided antibiotic therapy with a standard approach based on evidence-based guidelines for patients with ARTI in primary care.

Methods/Design

This is a randomised controlled trial in primary care with an open intervention. Adult patients judged by their general practitioner (GP) to need antibiotics for ARTI are randomised in equal numbers either to standard antibiotic therapy or to ProCT-guided antibiotic therapy. Patients are followed-up after 1 week by their GP and after 2 and 4 weeks by phone interviews carried out by medical students blinded to the goal of the trial.
Exclusion criteria for patients are antibiotic use in the previous 28 days, psychiatric disorders or inability to give written informed consent, not being fluent in German, severe immunosuppression, intravenous drug use, cystic fibrosis, active tuberculosis, or need for immediate hospitalisation.
The primary endpoint is days with restrictions from ARTI within 14 days after randomisation. Secondary outcomes are antibiotic use in terms of antibiotic prescription rate and duration of antibiotic treatment in days, days off work and days with side-effects from medication within 14 days, and relapse rate from the infection within 28 days after randomisation.

Discussion

We aim to include 600 patients from 50 general practices in the Northwest of Switzerland. Data from the registry of the Swiss Medical Association suggests that our recruited GPs are representative of all eligible GPs with respect to age, proportion of female physicians, specialisation, years of postgraduate training and years in private practice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schappert SM: Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital Health Stat 13. 1999, i-39. Schappert SM: Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital Health Stat 13. 1999, i-39.
2.
go back to reference Arroll B, Kenealy T: Antibiotics for the common cold and acute purulent rhinitis. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No :CD000247. 2002 Arroll B, Kenealy T: Antibiotics for the common cold and acute purulent rhinitis. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No :CD000247. 2002
3.
go back to reference Del Mar CB, Glasziou PP, Spinks AB: Antibiotics for sore throat. The Cochrane Database of Sytematic Reviews 2004, Issue 2 Art No :CD000023. 2004 Del Mar CB, Glasziou PP, Spinks AB: Antibiotics for sore throat. The Cochrane Database of Sytematic Reviews 2004, Issue 2 Art No :CD000023. 2004
4.
go back to reference Williams JW, Aguilar C, Cornell J, Chiquette E Dolor RJ, Makela M, Holleman DR, Simel DL: Antibiotics for acute maxillary sinusitis. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No :CD000243. 2002 Williams JW, Aguilar C, Cornell J, Chiquette E Dolor RJ, Makela M, Holleman DR, Simel DL: Antibiotics for acute maxillary sinusitis. The Cochrane Database of Systematic Reviews 2002, Issue 3 Art No :CD000243. 2002
5.
go back to reference Smucny J, Fahey T, Becker L, Glazier R: Antibiotics for acute bronchitis. The Cochrane Database of Systematic Reviews 2004, Issue 4 Art No :CD000245. 2004 Smucny J, Fahey T, Becker L, Glazier R: Antibiotics for acute bronchitis. The Cochrane Database of Systematic Reviews 2004, Issue 4 Art No :CD000245. 2004
6.
go back to reference Glasziou PP, Del Mar CB, Sanders SL, Hayem M: Antibiotics for acute otitis media in children. The Cochrane Database of Systematic Reviews 2003, Issue 4 Art No :CD000219. 2003 Glasziou PP, Del Mar CB, Sanders SL, Hayem M: Antibiotics for acute otitis media in children. The Cochrane Database of Systematic Reviews 2003, Issue 4 Art No :CD000219. 2003
7.
go back to reference Graham V, Lasserson TJ, Rowe BH: Antibiotics for acute asthma. The Cochrane Database of Systematic Reviews 2001, Issue 2 Art No :CD002741. 2001 Graham V, Lasserson TJ, Rowe BH: Antibiotics for acute asthma. The Cochrane Database of Systematic Reviews 2001, Issue 2 Art No :CD002741. 2001
8.
go back to reference Bjerre LM, Verheij TJM, Kochen MM: Antibiotics for community acquired pneumonia in adult outpatients. The Cochrane Database of Systematic Reviews 2004, Issue 2 Art No :CD002109. 2004 Bjerre LM, Verheij TJM, Kochen MM: Antibiotics for community acquired pneumonia in adult outpatients. The Cochrane Database of Systematic Reviews 2004, Issue 2 Art No :CD002109. 2004
9.
go back to reference Griffin JJ, Meduri GU: New approaches in the diagnosis of nosocomial pneumonia. Med Clin North Am. 1994, 78: 1091-1122.CrossRefPubMed Griffin JJ, Meduri GU: New approaches in the diagnosis of nosocomial pneumonia. Med Clin North Am. 1994, 78: 1091-1122.CrossRefPubMed
10.
go back to reference Gonzales R, Corbett K: The culture of antibiotics. Am J Med. 1999, 107: 525-526. 10.1016/S0002-9343(99)00302-2.CrossRefPubMed Gonzales R, Corbett K: The culture of antibiotics. Am J Med. 1999, 107: 525-526. 10.1016/S0002-9343(99)00302-2.CrossRefPubMed
11.
go back to reference Cunha BA: The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias. Med Clin North Am. 1995, 79: 581-597.CrossRefPubMed Cunha BA: The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias. Med Clin North Am. 1995, 79: 581-597.CrossRefPubMed
12.
go back to reference Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001, 163: 1730-1754.CrossRefPubMed Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001, 163: 1730-1754.CrossRefPubMed
13.
go back to reference Halm EA, Teirstein AS: Clinical practice. Management of community-acquired pneumonia. N Engl J Med. 2002, 347: 2039-2045. 10.1056/NEJMcp020499.CrossRefPubMed Halm EA, Teirstein AS: Clinical practice. Management of community-acquired pneumonia. N Engl J Med. 2002, 347: 2039-2045. 10.1056/NEJMcp020499.CrossRefPubMed
14.
go back to reference Mainous AGIII, Hueston WJ: The cost of antibiotics in treating upper respiratory tract infections in a medicaid population. Arch Fam Med. 1998, 7: 45-49. 10.1001/archfami.7.1.45.CrossRefPubMed Mainous AGIII, Hueston WJ: The cost of antibiotics in treating upper respiratory tract infections in a medicaid population. Arch Fam Med. 1998, 7: 45-49. 10.1001/archfami.7.1.45.CrossRefPubMed
15.
go back to reference Freeman J, Rosner BA, McGowan JEJ: Adverse effects of nosocomial infection. J Infect Dis. 1979, 140: 732-740.CrossRefPubMed Freeman J, Rosner BA, McGowan JEJ: Adverse effects of nosocomial infection. J Infect Dis. 1979, 140: 732-740.CrossRefPubMed
16.
go back to reference Schito GC, Debbia EA, Marchese A: The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother. 2000, 46 Suppl T1: 3-9.CrossRefPubMed Schito GC, Debbia EA, Marchese A: The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother. 2000, 46 Suppl T1: 3-9.CrossRefPubMed
17.
go back to reference Wenzel RP: The antibiotic pipeline--challenges, costs, and values. N Engl J Med. 2004, 351: 523-526. 10.1056/NEJMp048093.CrossRefPubMed Wenzel RP: The antibiotic pipeline--challenges, costs, and values. N Engl J Med. 2004, 351: 523-526. 10.1056/NEJMp048093.CrossRefPubMed
18.
go back to reference Guillemot D, Courvalin P: Better control of antibiotic resistance. Clin Infect Dis. 2001, 33: 542-547. 10.1086/322583.CrossRefPubMed Guillemot D, Courvalin P: Better control of antibiotic resistance. Clin Infect Dis. 2001, 33: 542-547. 10.1086/322583.CrossRefPubMed
19.
go back to reference Raz R, Porat V, Ephros M: Can an educational program improve the diagnosis and treatment of pharyngotonsillitis in the ambulatory care setting?. Isr J Med Sci. 1995, 31: 432-435.PubMed Raz R, Porat V, Ephros M: Can an educational program improve the diagnosis and treatment of pharyngotonsillitis in the ambulatory care setting?. Isr J Med Sci. 1995, 31: 432-435.PubMed
20.
go back to reference Santoso B, Suryawati S, Prawaitasari JE: Small group intervention vs formal seminar for improving appropriate drug use. Soc Sci Med. 1996, 42: 1163-1168. 10.1016/0277-9536(95)00390-8.CrossRefPubMed Santoso B, Suryawati S, Prawaitasari JE: Small group intervention vs formal seminar for improving appropriate drug use. Soc Sci Med. 1996, 42: 1163-1168. 10.1016/0277-9536(95)00390-8.CrossRefPubMed
21.
go back to reference Bexell A, Lwando E, von Hofsten B, Tembo S, Eriksson B, Diwan VK: Improving drug use through continuing education: a randomized controlled trial in Zambia. J Clin Epidemiol. 1996, 49: 355-357. 10.1016/0895-4356(95)00059-3.CrossRefPubMed Bexell A, Lwando E, von Hofsten B, Tembo S, Eriksson B, Diwan VK: Improving drug use through continuing education: a randomized controlled trial in Zambia. J Clin Epidemiol. 1996, 49: 355-357. 10.1016/0895-4356(95)00059-3.CrossRefPubMed
22.
go back to reference De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF: Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Med J Aust. 1994, 160: 502-505.PubMed De Santis G, Harvey KJ, Howard D, Mashford ML, Moulds RF: Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Med J Aust. 1994, 160: 502-505.PubMed
23.
go back to reference Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ: Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ. 2004, 329: 431-10.1136/bmj.38182.591238.EB.CrossRefPubMedPubMedCentral Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ: Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ. 2004, 329: 431-10.1136/bmj.38182.591238.EB.CrossRefPubMedPubMedCentral
24.
go back to reference Zwar N, Wolk J, Gordon J, Sanson-Fisher R, Kehoe L: Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Fam Pract. 1999, 16: 495-500. 10.1093/fampra/16.5.495.CrossRefPubMed Zwar N, Wolk J, Gordon J, Sanson-Fisher R, Kehoe L: Influencing antibiotic prescribing in general practice: a trial of prescriber feedback and management guidelines. Fam Pract. 1999, 16: 495-500. 10.1093/fampra/16.5.495.CrossRefPubMed
25.
go back to reference Gonzales R, Steiner JF, Lum A, Barrett PHJ: Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999, 281: 1512-1519. 10.1001/jama.281.16.1512.CrossRefPubMed Gonzales R, Steiner JF, Lum A, Barrett PHJ: Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999, 281: 1512-1519. 10.1001/jama.281.16.1512.CrossRefPubMed
26.
go back to reference Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993, 341: 515-518. 10.1016/0140-6736(93)90277-N.CrossRefPubMed Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993, 341: 515-518. 10.1016/0140-6736(93)90277-N.CrossRefPubMed
27.
go back to reference Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000, 28: 977-983. 10.1097/00003246-200004000-00011.CrossRefPubMed Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000, 28: 977-983. 10.1097/00003246-200004000-00011.CrossRefPubMed
28.
go back to reference Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001, 164: 396-402.CrossRefPubMed Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001, 164: 396-402.CrossRefPubMed
29.
go back to reference Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004, 39: 206-217. 10.1086/421997.CrossRefPubMed Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004, 39: 206-217. 10.1086/421997.CrossRefPubMed
30.
go back to reference Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004, 363: 600-607. 10.1016/S0140-6736(04)15591-8.CrossRefPubMed Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004, 363: 600-607. 10.1016/S0140-6736(04)15591-8.CrossRefPubMed
31.
go back to reference Christ-Crain M, Jaccard-Stolz D, Bingisser R, Huber PR, Leuppi J, Mueller C, Tamm M, Muller B: Procalcitonin guidance significantly reduces antibiotic duration in community acquired pneumonia. Proc 25th Int Congress of Intensive and Emergency Medicine (ISICEM). 2005, P166- Christ-Crain M, Jaccard-Stolz D, Bingisser R, Huber PR, Leuppi J, Mueller C, Tamm M, Muller B: Procalcitonin guidance significantly reduces antibiotic duration in community acquired pneumonia. Proc 25th Int Congress of Intensive and Emergency Medicine (ISICEM). 2005, P166-
32.
go back to reference Scott JG, Cohen D, DiCicco-Bloom B, Orzano AJ, Jaen CR, Crabtree BF: Antibiotic use in acute respiratory infections and the ways patients pressure physicians for a prescription. J Fam Pract. 2001, 50: 853-858.PubMed Scott JG, Cohen D, DiCicco-Bloom B, Orzano AJ, Jaen CR, Crabtree BF: Antibiotic use in acute respiratory infections and the ways patients pressure physicians for a prescription. J Fam Pract. 2001, 50: 853-858.PubMed
33.
go back to reference Kumar S, Little P, Britten N: Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003, 326: 138-10.1136/bmj.326.7381.138.CrossRefPubMedPubMedCentral Kumar S, Little P, Britten N: Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003, 326: 138-10.1136/bmj.326.7381.138.CrossRefPubMedPubMedCentral
34.
go back to reference Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC: Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004, 38: 348-356. 10.1086/380964.CrossRefPubMed Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC: Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004, 38: 348-356. 10.1086/380964.CrossRefPubMed
35.
go back to reference Poses RM, Cebul RD, Wigton RS: You can lead a horse to water--improving physicians' knowledge of probabilities may not affect their decisions. Med Decis Making. 1995, 15: 65-75.CrossRefPubMed Poses RM, Cebul RD, Wigton RS: You can lead a horse to water--improving physicians' knowledge of probabilities may not affect their decisions. Med Decis Making. 1995, 15: 65-75.CrossRefPubMed
36.
go back to reference Wensing M, Grol R: Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care. 1994, 6: 115-132.CrossRefPubMed Wensing M, Grol R: Single and combined strategies for implementing changes in primary care: a literature review. Int J Qual Health Care. 1994, 6: 115-132.CrossRefPubMed
37.
go back to reference Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001, 134: 479-486.CrossRefPubMed Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001, 134: 479-486.CrossRefPubMed
38.
go back to reference Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med. 2001, 134: 490-494.CrossRefPubMed Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med. 2001, 134: 490-494.CrossRefPubMed
39.
go back to reference Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001, 134: 498-505.CrossRefPubMed Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med. 2001, 134: 498-505.CrossRefPubMed
40.
go back to reference Cooper RJ, Hoffman JR, Bartlett JG, Besser RE, Gonzales R, Hickner JM, Sande MA: Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med. 2001, 134: 509-517.CrossRefPubMed Cooper RJ, Hoffman JR, Bartlett JG, Besser RE, Gonzales R, Hickner JM, Sande MA: Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med. 2001, 134: 509-517.CrossRefPubMed
41.
go back to reference Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001, 134: 521-529.CrossRefPubMed Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, Sande MA: Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med. 2001, 134: 521-529.CrossRefPubMed
42.
go back to reference Snow V, Lascher S, Mottur-Pilson C: Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001, 134: 595-599.CrossRefPubMed Snow V, Lascher S, Mottur-Pilson C: Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001, 134: 595-599.CrossRefPubMed
43.
go back to reference Moher D, Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001, 134: 657-662.CrossRefPubMed Moher D, Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med. 2001, 134: 657-662.CrossRefPubMed
Metadata
Title
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]
Authors
Matthias Briel
Mirjam Christ-Crain
Jim Young
Philipp Schuetz
Peter Huber
Pierre Périat
Heiner C Bucher
Beat Müller
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Primary Care / Issue 1/2005
Electronic ISSN: 2731-4553
DOI
https://doi.org/10.1186/1471-2296-6-34

Other articles of this Issue 1/2005

BMC Primary Care 1/2005 Go to the issue